NCT07123740 Comparison of the Postoperative Analgesic Effects of ITM and Bi-level ESPB in Liver Transplantation Donors
| NCT ID | NCT07123740 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara Etlik City Hospital |
| Condition | Liver Transplantation |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-08-18 |
| Primary Completion | 2026-07-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-08-18 with a primary completion date of 2026-07-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Liver transplantation is a life-saving procedure for patients with end-stage liver disease, and postoperative pain management is critical for optimizing donor recovery and overall outcomes. Poorly controlled pain following donor hepatectomy may reduce quality of life, delay mobilization, and contribute to the development of chronic pain syndromes. Regional anesthesia techniques, such as intrathecal morphine and erector spinae plane block, have been utilized to enhance postoperative analgesia and reduce perioperative opioid requirements, potentially minimizing opioid-related adverse effects. In this study, we aimed to compare the postoperative analgesic efficacy of intrathecal morphine and Bi-level erector spinae plane block in living liver donors.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18-65 years * American Society of Anesthesiologists (ASA) score I-II * Body Mass Index (BMI) between 18-30 kg/m2 Exclusion Criteria: * Patients under 18 and over 65 years of age * ASA score III and above * Patients with a history of bleeding diathesis * BMI below 18 or above 30 kg/m2
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07123740 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Liver Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07123740 currently recruiting?
Yes, NCT07123740 is actively recruiting participants. Contact the research team at kansezgi@gmail.com for enrollment information.
Where is the NCT07123740 trial being conducted?
This trial is being conducted at Altındağ, Turkey (Türkiye).
Who is sponsoring the NCT07123740 clinical trial?
NCT07123740 is sponsored by Ankara Etlik City Hospital. The trial plans to enroll 60 participants.